Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/ anti hyperglycaemia in normal/alloxan-induced diabetic rats

Molecular and Cellular Biochemistry

Volumn 283, Issue 1-2, 2006, Pages 123-127

  Satyanarayana, S ^a   Sekhar, J Raja ^a   Kumar, K Eswar ^a   Shannika, L Bacchus ^b   Rajanna, Bettaiya ^b   Rajanna, Sharada ^b  

^a ANDHRA UNIVERSITY   (India)

^b ALCORN STATE UNIVERSITY   (United States)

Author keywords

Antihyperglycaemia; Blood glucose; Diabetes; Gliclazide; Hypoglycaemia; Selenium

Indexed keywords

ALLOXAN; ANTIOXIDANT; GLICLAZIDE; GLUCOSE; SELENIUM; ANTIDIABETIC AGENT;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; FEMALE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; METABOLISM; ORAL DRUG ADMINISTRATION;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; FEMALE; GLICLAZIDE; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; RATS; SELENIUM;

EID: 33645792371     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-2387-2     Document Type: Article

References (28)

1. Kingh N, Aubert RE, Heiman WH: Prevalence: numerical estimates and projections. Global burden of diabetes, 1995-2025. Diabetes Care 21: 1414-1431, 1998
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Cittle RR, Miedmeyer HM, Byrd, Holt DD: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey 1988-1994. Diabetes Care 21: 518-524, 1998
3. Ziegler P, Drouin P: Hemobiological properties of gliclazide. J Diabetes Complicat 8(4): 235-239, 1994
4. Collier A, Wilson R, Bradley H, Thomson JA, Small M: Freeradical activity in type diabetes. Diabetic Med 7: 27-30, 1990
5. Nourooz-Zadesh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betterdige DJ: Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40: 647-653, 1997
6. Sreemantula S, Kilari EK, Vardhan VA, Jaladi R: Influence of anti oxidant (L-ascorbic acid) on tolbutamide-induced hypoglycaemia/anti hyperglycaemia in normal and diabetic rats. BMC endocrine disorders 5: 2, 2005
7. Douillet C, Tabib A, Bost M, Accominoth M, Broson-Chazot F, Civatti M: Selenium in diabetes: Effects of selenium on nephropathy in type-I streptozotociun induced diabetic rats. J Trace Elem Exp Med 12: 379-392, 1999
8. Lawrence DR, Bacharach AL (eds.): Evaluation of drug activities: Pharmacometrics. Vol. 1, Academic Press, New York, 1964
9. Trinder P: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6: 24, 1969.
10. Lawrence JC, Jill SG, Eric PD, Joyle AD, Donald DL, Mark AY: Effect of antioxidant treatment on streptozotocin induced diabetic rats on endoneural blood flow, motor nerve conduction velocity and vascular reactivity of epineural arterioles of the sciatic nerve. Diabetes 50: 1927-1937, 2001
11. Oberly LW: Free radicals and diabetes. Free Radic Biol Med 5: 113-124, 1988
12. West IC: Radicals and oxidative stress in diabetes. Diabetic Med 17: 171-180, 2000
13. McNeill JH, Delgatty HL, Battell ML: Insulin like effects of sodium selenate in STZ induced diabetic rats diabetes 40(12): 1675-1678, 1991
14. Ghosh R, Mukharjee B, Chatterjee M: A novel effect of selenium on streptozotocin induced diabetic mice. Diabetic Res 25(4): 1165-1171, 1994
15. Sheng Xq, Huang Kx, Xu HB: New experimental observation on the relationship of selenium and diabetes mellitus. Biol Trace Elem Res 99(1-3): 241-253, 2004
16. Osamu Ezaki: Insulin like effects of selenium in rat adipocytes. J Biol Chem 265(2): 1124-1128, 1990
17. Riley V: Adaptation of orbital bleeding technique to rapid serial blood studies. Proc Soc Exp Biol Med 104: 751-754, 1960
18. Heikkila RE: The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur J Pharmacol 44(2): 191-193, 1977
19. Lizuka Y, Sakhurai E, Hichi N: Effects of selenium on serum glucose and insulin levels in diabetic rats. Nippom Yakurigakuzashi August 100(2): 151-156, 1992
20. Madar J, Dicter N, Tirosh O: Selenium antioxidant activity may impair glucose metabolism in rats. 18th International Diabetes Federation Congress, August 24-29, 2003, Paris, France. OP 20 nutrition 155
21. Viggneri R, Pezzino V, Wang KY: Comparison of the in-vitro effect of biguanides and sulfonylureas on the insulin binding of its receptors in target cells. J Clin Endocrinol Metab 54: 95-100. 1982
22. Campbell DB, Lavielle R, Nathan C: The mode of action on clinical pharmacology of gliclazide: A review. Diabetes Res Clin Pract 14(Suppl 2): S21-S36, 1991
23. Chiasson JL, Hamet P, Vercly M: The effect of Diamicron(R) on the secretion and action of insulin. Diabetes Res Clin Pract 14: S47-S51, 1991
24. Ma A, Kamp M, Bird D: The effects of long term gliclazide administration on insulin secretion and insulin sensitivity. Aus NZ J Med 19: 44-49, 1989
25. Vanhaeften TW, Vaneman TF, Gerich JE: Influence of Gliclazide on glucose stimulated insulin release in man. Metabolism 40: 751-755, 1991
26. Wajchenberg BL, Santomano ATMG, Porrelli RN: Effect of sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose mediated, glucose disposal in patients with non-insulin dependent diabetes mellitus (NIDDM). Diabetes Res Clin Pract 20: 147-154, 1993
27. Ruhe RC, McDonald RB: Use of antioxidant nutrients in the prevention and treatment of type-II diabetes. J Am Coll Nutr 20(5): 363S-369S, 2001
28. Abdel-Wanhab YH, O'Harte FP, Mooney MH, Barnett CR, Flatt PR: Vitamin C supplementation decreases insulin glyclation and improves glucose homeostasis in obese hyperglycaemic (ob/ob) mice metabolism 51: 514-517, 2002